A California drug maker says its new cholesterol drug could work wonders for people genetically predisposed to high cholesterol.

Amgen Inc. says patients injected with AMG-145 once a month showed more improvement as opposed to taking statin drugs alone. The trial lasted for 12 weeks. 

It's not clear when the company will bring the drug to market.